Intracerebroventricular administration of endothelin-1 impairs the habituation of rats to a novel environment in conjunction with brain serotonergic activation

Neuroscience

Volumn 117, Issue 2, 2003, Pages 449-460

  Takeda, H ^a   Tsuji, M ^a   Fujisawa, Y ^a   Yamada, T ^a   Tsuji, K ^a   Egashira, T ^b   Matsumiya, T ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b OITA UNIVERSITY   (Japan)

Author keywords

5 HT; Adaptation; Brain; Emotionality; Endothelin; Novel environmental stress

Indexed keywords

ENDOTHELIN 1; FENCLONINE; SEROTONIN; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; EMOTION; ENVIRONMENTAL EXPOSURE; HABITUATION; HIPPOCAMPUS; LOCOMOTION; MALE; MESENCEPHALON; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; SEROTONIN METABOLISM; SEROTONINERGIC SYSTEM;

EID: 0037459803     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00871-0     Document Type: Article

References (57)

1. Arai H., Hori S., Aramori I., Ohkubo H., Nakanishi S. Cloning and expression of cDNA encoding an endothelin receptor. Nature. 348:1990;730-732.
2. Barnes N.M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology. 38:1999;1083-1152.
3. Battistini B., Dussault P. The many aspects of endothelins in ischemia-reperfusion injury emergence of a key mediator. J Invest Surg. 11:1998;297-313.
4. Boissier J.R., Simon P. La reaction d'exploration chez la souris. Therapie. 17:1962;1225-1232.
5. Boissier J.R., Simon P. Dissociation de deux composantes dans le compartment d'investigation de la souris. Arch Int Pharmacodyn. 147:1964;372-387.
6. Chew B.H., Weaver D.F., Balaban C.D., Gross P.M. NMDA-mediated metabolic activation of the cerebellar cortex in behaving rats by the neuropeptide endothelin-1. Brain Res. 647:1994;345-352.
7. Chew B.H., Weaver D.F., Gross P.M. Dose-related potent brain stimulation by the neuropeptide endothelin-1 after intraventricular administration in conscious rats. Pharmacol Biochem Behav. 51:1995;37-47.
8. A selective non-peptide radiolabelled antagonist, in normal and diseased human tissues. Br J. Pharmacol. 123:1998;223-230.
9. Deschepper C.F., Houweling A.D., Picard S. The membranes of cultured rat brain astrocytes contain endothelin-converting enzyme activity. Eur J Pharmacol. 275:1995;61-66.
10. B) in human cerebral cortex using subtype-selective ligands. J Neurochem. 62:1994;1482-1488.
11. Fuxe K., Tinner B., Staines W., Hemsen A., Hersh L., Lundberg J.M. Demonstration and nature of endothelin-3-like immunoreactivity in somatostatin and choline acetyltransferase-immunoreactive nerve cells of the neostriatum of the rat. Neurosci Lett. 123:1991;107-111.
12. Giaid A., Gibson S.J., Ibrahim N.B.N., Leyon S., Bloom S.R., Yanagisawa M., Masaki T., Varndell I.M., Polak J.M. Endothelin 1, and endothelin-derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganglia. Proc Natl Acad Sci USA. 86:1989;7634-7638.
13. Gross P.M., Beninger R.J., Shaver S.W., Wainman D.S., Espinosa F.J., Weaver D.F. Metabolic and neuroanatomical correlates of barrel-rolling and oculoclonic convulsions induced by intraventricular endothelin-1 a novel peptidergic signaling mechanism in visuovestibular and oculomotor regulation? Exp Brain Res. 95:1993;397-408.
14. Gross P.M., Weaver D.F., Ho L.T., Pang J.J., Edvinsson L. FR139317, a specific ETA-receptor antagonist, inhibits cerebral activation by intraventricular endothelin-1 in conscious rats. Neuropharmacology. 33:1994;1155-1166.
15. Gulati A., Srimal R.C. Endothelin mechanisms in the central nervous system-A target for drug development. Drug Dev Res. 26:1992;361-387.
16. Haynes W.G., Davenport A.P., Webb D.J. Endothelin Progress in pharmacology and physiology. Trends Pharmacol Sci. 14:1993;225-228.
17. Hemsen A., Lundberg J.M. Presence of endothelin-1 and endothelin-3 in peripheral tissues and central nervous system of the pig. Regul Pept. 36:1991;71-83.
18. Hori S., Komastu Y., Shigemoto R., Mizuno N., Nakanishi S. Distinct tissue distribution and cellular localization of two messenger ribonucleic acid encoding different subtypes of rat endothelin receptors. Endocrinology. 130:1992;1885-1895.
19. Horie K., Morita A., Yokogoshi H. Endothelin-1 and endothelin-3 modulate dopaminergic neurons through different mechanisms. Life Sci. 57:1995;735-741.
20. Inoue A., Yanagisawa M., Kimura S., Kasuya Y., Miyauchi T., Goto K., Masaki T. The human endothelin family Three structurally and pharmacologically distinct isopepitde predicted by three separate genes. Proc Natl Acad Sci USA. 86:1989;2863-2867.
21. 1A receptor antagonists, WAY-100 635 and NDL-249, stimulate locomotion in rats acclimatized to their environment and alter their behavior a behavioural analysis. Psychopharmacology. 139:1998;300-310.
22. Jiang M.H., Hoog A., Ma K.C., Nie X.J., Olsson Y., Zhang W.W. Endothelin-1-like immunoreactivity is expressed in human reactive astrocytes. Neuroreport. 4:1993;935-937.
23. 125I]endothelin in rat and human brain. Neurosci Lett. 97:1989;276-279.
24. Koizumi S., Kataoka Y., Niwa M., Kumakura K. Endothelin-3 stimulates the release of catecholamine from cortical and striatal slices of the rat. Neurosci Lett. 134:1992;219-222.
25. Koizumi S., Kataoka Y., Niwa M., Watanabe S., Taniyama K. Two distinct pathways are involved in the endothelin-3-evoked dopamine release from rat striatal slices. Eur J Pharmacol. 259:1994;195-201.
26. Konya H., Nagai K., Matsuda H., Kakishita E. Endothelin-3 modification of dopamine release in anaesthetized rat striatum; an in vivo microdialysis. Life Sci. 51:1992;499-506.
27. Koseki C., Imai M., Hirata Y., Yanagisawa M., Masaki T. Autoradiographic distribution in rat tissues of binding sites for endothelin a neuropeptide? Am J Physiol. 256:1989;R858-R866.
28. 125I]endothelin-1 binding sites in rat brain. Neurosci Res. 6:1989;581-585.
29. Kurihara Y., Kurihara H., Morita H., Cao W.H., Ling G.Y., Kumada M., Kimura S., Nagai R., Yazaki Y., Kuwaki T. Role of endothelin-1 in stress response in the central nervous system. Am J Physiol Regul Integr Comp Physiol. 279:2000;R515-R521.
30. Kuwai T., Kurihara H., Cao W.H., Kurihara Y., Unekawa M., Yazaki Y., Kumada M. Physiological role of brain endothelin in the central autonomic control from neuron to knockout mouse. Prog Neurobiol. 51:1997;545-579.
31. Lee M.E., De la Monte S.M., Ng S.C., Block K.D., Quertermous T. Expression of the potent vasoconstrictor endothelin in the human central nervous system. J Clin Invest. 86:1990;141-147.
32. Li J., Takeda H., Tsuji M., Lui L., Matsumiya T. Antagonism of central CRF systems mediates stress-induced changes in noradrenaline and serotonin turnover in rat brain regions. Methods Find Exp Clin Pharmacol. 20:1998;409-417.
33. Liu L., Tsuji M., Takeda H., Takada K., Matsumiya T. Adrenocortical suppression blocks the enhancement of memory storage produced by exposure to psychological stress in rats. Brain Res. 821:1999;134-140.
34. Ma K.C., Nie X.J., Hoog A., Olsson Y., Zhang W.W. Reactive astrocytes in viral infections of the human brain express endothelin-like immunoreactivity. J Neurol Sci. 126:1994;184-192.
35. MacCumber M.W., Ross C.A., Glaser B.M., Snyder S.H. Endothelin visualization of mRNAs by in situ hybridization provides evidence for local action. Proc Natl Acad Sci USA. 86:1989;7285-7289.
36. Masaki T., Yanagisawa M., Goto K. Physiology and pharmacology of endothelins. Med Res Rev. 12:1992;391-421.
37. Masuo Y., Matsumoto Y., Morita S., Noguchi J. A novel method for counting spontaneous motor activity in the rat. Brain Res Protocols. 1:1997;321-326.
38. Matsumoto H., Suzuki N., Onda H., Fujino M. Abundance of endothelin-3 in rat intestine, pituitary gland and brain. Biochem Biophys Res Commun. 164:1989;74-80.
39. Murphy D.L., Wichems C., Li Q., Heils A. Molecular manipulations as tools for enhancing our understanding of 5-HT neurotransmission. Trends Pharmacol Sci. 20:1999;246-252.
40. Nagasaka J., Tsuji M., Takeda H., Matsumiya T. Role of endothelin receptor subtypes in the behavioral effects of the intracerebroventricular administration of endothelin-1 in conscious rats. Pharmacol Biochem Behav. 64:1999;171-176.
41. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1982;Academic Press, New York. 2nd ed.
42. Rodriguez Echandia E.L., Broitman S.T., Foscolo M.R. Effect of the chronic ingestion of chlorimipramine and desipramine on the hole board response to acute stresses in male rats. Pharmacol Biochem Behav. 26:1987;207-210.
43. Sakurai T., Yanagisawa M., Takuwa Y., Miyazaki H., Kimura S., Goto K., Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of endothelin receptor. Nature. 348:1990;732-735.
44. A receptor exists in the caudal solitary tract nucleus of the rat brain. Cell Mol Neurobiol. 17:1997;151-156.
45. Sluck J.M., Lin R.C.S., Katolik L.I., Jeng A.Y., Lehmann J.C. Endothelin converting enzyme-1-, endothelin-1-, and endothelin-3-like immunoreactivity in the rat brain. Neuroscience. 91:1999;1483-1497.
46. Takeda H., Matsumiya T., Shibuya T. Detection and identification modes for the highly selective and simultaneous determination of various biogenic amines by coulometric high-performance liquid chromatography. J Chromatogr. 515:1990;265-278.
47. Takeda H., Tsuji M., Matsumiya T. Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice. Eur J Pharmacol. 350:1998;21-29.
48. 1A receptor agonists and benzodiazepine anxiolytics on the emotional state of na ï ve and stressed mice a study using the hole-board test. Psychopharmacology. 152:2000;157-166.
49. 1A receptor agonists against emotional changes produced by stress stimuli are related to their neuroendocrine effects. Br J Pharmacol. 134:2001;585-595.
50. Van den Buuse M., Webber K.M. Endothelin and dopamine release. Prog Neurobiol. 60:2000;385-405.
51. Warner T.D., Budzik G.P., Matsumoto T., Mitchell J.A., F ö ratermann U., Murad F. Regional differences in endothelin converting enzyme activity in rat brain Inhibition by phosphoramidon and EDTA. Br J Pharmacol. 106:1992;948-952.
52. B receptor. Brain Res. 724:1996;180-185.
53. Webber K.M., Pennefather J.N., Head G.A., van den Buuse M. Endothelin induces dopamine release from rat striatum via endothelin-B receptors. Neuroscience. 86:1998;1173-1180.
54. Williams D.L., Jones K.L., Colton C.D., Nutt R.F. Identification of high affinity endothelin-1 receptor subtypes in human tissues. Biochem Biophys Res Commun. 180:1991;475-480.
55. Yamamoto T., Suzuki H., Uemura H. Endothelin B receptor-like immunoreactivity is associated with LHRH-immunoreactive fibers in the rat hypothalamus. Neurosci Lett. 223:1997;117-120.
56. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.
57. Zhang W.W., Badonic T., Hoog A., Jiang M.H., Ma K.C., Nie X.J., Olsson Y. Astrocytes in Alzheimer's disease express immunoreactive to the vasoconstrictor endothelin-1. J Neurol Sci. 122:1994;90-96.